ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 171 filers reported holding ANI PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $17,362,000 | -13.8% | 426,162 | +30.4% | 2.40% | -18.8% |
| Q4 2019 | $20,152,000 | -45.8% | 326,778 | -35.9% | 2.95% | -34.5% |
| Q3 2019 | $37,165,000 | -17.7% | 509,952 | -7.2% | 4.50% | -11.8% |
| Q2 2019 | $45,161,000 | +16.5% | 549,401 | 0.0% | 5.11% | -1.5% |
| Q1 2019 | $38,755,000 | +56.7% | 549,401 | 0.0% | 5.18% | +57.3% |
| Q4 2018 | $24,734,000 | -14.6% | 549,401 | +7.2% | 3.29% | +80.5% |
| Q3 2018 | $28,971,000 | +9.3% | 512,401 | +29.1% | 1.82% | +6.9% |
| Q2 2018 | $26,514,000 | +21.0% | 396,923 | +5.5% | 1.71% | +19.5% |
| Q1 2018 | $21,909,000 | -9.7% | 376,314 | 0.0% | 1.43% | -56.4% |
| Q4 2017 | $24,253,000 | +22.8% | 376,314 | 0.0% | 3.27% | -3.3% |
| Q3 2017 | $19,753,000 | +50.8% | 376,314 | +34.5% | 3.38% | +26.7% |
| Q2 2017 | $13,098,000 | +353.2% | 279,866 | +379.4% | 2.67% | +304.1% |
| Q1 2017 | $2,890,000 | – | 58,375 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |